Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

AstraZeneca LP

Division of AstraZeneca PLC

Latest From AstraZeneca LP

Will $2.5Bn Jury Verdict Against Gilead Stand? Future Royalties, Willful Infringement Penalty Uncertain

Gilead is appealing a jury finding that it must pay Merck 10% royalty on sales of Sovaldi and Harvoni through August 2016; judge could find the firm owes treble the amount for willful infringement.

Legal Issues Intellectual Property

Will $2.5Bn Jury Verdict Against Gilead Stand? Future Royalties, Willful Infringement Penalty Uncertain

Gilead is appealing a jury finding that it must pay Merck 10% royalty on sales of Sovaldi and Harvoni through August 2016; judge could find the firm owes treble the amount for willful infringement.

Intellectual Property Legal Issues

Legal News, In Brief: FDA Opposes Otsuka Suit; Apotex Can Challenge Benicar Patent

FDA asks court to dismiss Otsuka’s Abilify suit; Apotex can seek infringement ruling on disclaimed Benicar patent; Apotex damages for omeprazole launch must be recalculated; hedge fund manager Kyle Bass files IPR petitions against Jazz and Shire.

BioPharmaceutical United States

Patent Defense Strategy: Court Halts Actavis Launch Of Generic Pulmicort

Federal Circuit again rescues AstraZeneca’s pediatric asthma product – at least until a hearing.

BioPharmaceutical United States
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Astra Pharmaceuticals LP
  • Astra Merck Inc.
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • AstraZeneca PLC
  • Senior Management
  • Carl G Johansson, Pres. & CEO
    Russell Gantt, VP, Licensing, N. America
    Deni Deasy, Dir., Strategic Planning & Bus. Dev.
  • Contact Info
  • AstraZeneca LP
    Phone: (508) 366-1100
    50 Otis St.
    Westborough, MA 01581-3323
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register